Jinfa Ren1, Dongming Han1, Xiaoyang Zhai1, Huijia Yin1, Ruifang Yan1, and Kaiyu Wang2
1Department of MR, The First Affiliated Hospital of Xinxiang Medical University, Weihui, China, 2GE Healthcare, MR Research China, Beijing, China
Synopsis
Keywords: Machine Learning/Artificial Intelligence, Radiomics
Detecting true tumor
recurrence and treatment-related effects in glioma after treatment is crucial for patient managements and challenging via conventional MRI for
differentiation. Radiomics can be used to access the details in the images in
an objective way. We constructed models based on multiple modalities by using
radiomics features of the postoperative enhanced and edematous regions to find
key features for identifying true tumor recurrence. Features from CE-T1WI and enhanced
regions have excellent classification performance, and the model of
multimodality with whole regions is the best, which may aid clinicians in
developing individualized treatment strategies.
Introduction
Patients treated with
radiotherapy or concurrent chemoradiotherapy after glioma surgery can encounter the change the permeability of the
blood-brain barrier, resulting in contrast leakage and, thus varying degrees of
enhancement or occupancy at contrast-enhanced T1-weighted image (CE-T1WI)1. Notably, depending on such enhancement patterns, it remains
challenging to differentiate true tumor recurrence (TuR) and
treatment-related effects (TrE), let
alone to identify early recurrence or malignant
transformation, regardless the fact that the two corresponding treatments are
distinctive2. However, multimodal radiomics features can potentially be used to
identify TuR in glioma3,4. We evaluated the performance of different sequences in recognizing
recurrence status based on radiomics features extracted from postoperative enhancement (PoE) and edematous
(ED) areas during daily follow-up.Methods
A total of 131 patients were enrolled in the primary cohort and randomly divided into the training set (N=91) and the test set (N=40), then their data were proceeded as the workflow in Fig.1. Radiomics features were extracted from the
postoperative enhancement (PoE) region and adjacent edema (ED) region from four routine MRI sequences, including T1-weighted
image (T1WI), T2-weighted image (T2WI), T2-weighted fluid attenuated
inversion recovery (T2-FLAIR) and CE-T1WI. After analyses of intraclass
correlation coefficient, Spearman's rank correlation coefficient, and least
absolute shrinkage and selection operator, the key radiomics features were
selected and subsequently utilized to construct Support Vector Machine (SVM)
models. Decision curve analysis (DCA) and receiver operating characteristic
(ROC) curves were used to analyze the performance in the test set.Results
After
feature selection, a dataset with 72 key radiomics features that consist
of 38 features from the PoE area and 34 from the ED area was obtained. We found that the model with features from the PoE and ED region (Fig.2)
could be used to well distinguish TuR from TrE. In the ROC analyses, the area under the curve (AUC) of the PoE region model
was higher than that of the ED region model (P < 0.05). Among the models
constructed with a single sequence, the model using PoE regional features from
CE-T1WI (Fig.3A) was superior to other models (Fig.3B), with an
AUC of 0.960 for SVM. In multimodality models, PoE features outperform ED
features with an AUC of 0.931. When combining four MRI sequences and all
regional features, a slightly better performance was achieved with an AUC of 0.965
(Fig.3C). The DCA indicated
that if the threshold probability of clinical decision was greater than 0.05,
all models added more benefit than the scheme of treat-none or
treat-all-patients. When the threshold probability was over 0.31 for
identifying TuR, the multi-region model brought more benefit than either the
PoE or ED model alone in most cases (Fig.4). The model based on features of
CE-T1WI from PoE region was outstanding and in most
time was even better than multimodality model of the whole region when the threshold probability was less than 0.8, while the latter was way
better when the threshold probability was greater than 0.8.Discussion
Our study demonstrates
that it is possible to identify recurrence using the radiomics features of the
edema area despite the commonly acknowledged PoE
area. This result confirmed the hypothesis that the
texture information of the edema area could potentially provide valid
information for detecting TuR. However, the classification performance of the
model constructed based on the features from edema region was inferior to that
of the PoE region.
When combined four MRI sequences
and all regional features together, the model showed a slightly better
performance than based on PoE regional features from CE-T1WI. The features of the PoE region from CE-T1WI can fully reflect the
course of angiogenesis within the tumor. This may help to reveal the
differences between TuR and TrE pathologically.
Additionally, the DCA analysis showed that the CE-T1WI
model of PoE region and multimodality model of whole region had better clinical utility and
resulted in a higher net benefit to patients in clinical decision making. It
may assist postoperative glioma patients with risk stratification and survival
prediction, which is consistent with previous findings. Furthermore, by merging
the multimodality imaging features of MRI, the best features from each sequence
were chosen independently to ensure a comprehensive modeling. Global textural
features were also used, which may reflect the heterogeneity and aggressiveness
of the tumor. In both the training and test sets, our model is able to
adequately distinguish between TuR and TrE, and has diagnostic robustness. This
allows clinicians to identify patients who are most likely to benefit from
additional surgery.Conclusion
Multimodality radiomics models from both PoE and ED regions have the best performance in identifying TuR
and TrE, potentially aiding clinical decision-making for individualized
treatment. Features from CE-T1WI and enhanced regions have excellent classification
performance in comparison with features from other sequences in PoE or ED regions. And edematous regions can provide useful information for
recognizing recurrence.Acknowledgements
No acknowledgement found.References
1. Sharma, H. S.; Muresanu, D. F.; Castellani, R. J.; Nozari, A.;
Lafuente, J. V.; Tian, Z. R.; Sahib, S.;
Bryukhovetskiy, I.;
Bryukhovetskiy, A.; Buzoianu, A.
D.; Patnaik, R.; Wiklund, L.; Sharma, A., Pathophysiology of
blood-brain barrier in brain tumor. Novel therapeutic advances using
nanomedicine. International review of
neurobiology 2020, 151, 1-66.
2. Salvati, M.; Pesce,
A.; Palmieri, M.; Floriana Brunetto, G. M.; Santoro, A.; Frati, A., The Role and Real
Effect of an Iterative Surgical Approach for the Management of Recurrent
High-Grade Glioma: An Observational Analytic Cohort Study. World neurosurgery 2019.
3. Shim, K. Y.; Chung, S.
W.; Jeong, J. H.; Hwang, I.;
Park, C. K.; Kim, T. M.; Park, S. H.;
Won, J. K.; Lee, J. H.; Lee, S. T.;
Yoo, R. E.; Kang, K. M.; Yun, T. J.;
Kim, J. H.; Sohn, C. H.; Choi, K. S.; Choi, S. H., Radiomics-based
neural network predicts recurrence patterns in glioblastoma using dynamic
susceptibility contrast-enhanced MRI. Scientific
reports 2021, 11 (1), 9974.
4. Chougule, T.; Gupta, R.
K.; Saini, J.; Agrawal, S.;
Gupta, M.; Vakharia, N.; Singh, A.;
Patir, R.; Vaishya, S.;
Ingalhalikar, M., Radiomics signature for temporal evolution and recurrence
patterns of glioblastoma using multimodal magnetic resonance imaging. NMR in biomedicine 2022, 35 (3), e4647.